Kevin Loring Winthrop MD
Assistant Professor, Ophthalmology, Oregon Health and Science University
Join to View Full Profile
3375 SW Terwilliger BlvdPortland, OR 97239
Phone+1 503-494-7890
Fax+1 503-494-0470
Are you Dr. Winthrop?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Winthrop, MD is an infectious disease specialist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and California. He is an Assistant Professor at Oregon Health and Science University.
Education & Training
Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 2004 - 2006
California Department of Public HealthFellowship, Maxillofacial Pathology, 2002 - 2002
Oregon Health and Science University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - Present
WA State Medical License 2024 - 2026
OR State Medical License 2004 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.Ai Li Yeo, Kevin L Winthrop
Clinics in Chest Medicine. 2025-03-01 - Choosing Wisely: Effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of Invasive Group A Streptococci Infection.Marina G Birck, Cristiano S Moura, Kevin L Winthrop, Marina A A Machado, Autumn Neville
Clinical Infectious Diseases. 2025-02-24 - Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consen...Victoria Konzett, Josef S Smolen, Peter Nash, Daniel Aletaha, Kevin Winthrop
Annals of the Rheumatic Diseases. 2025-02-10
Press Mentions
Zoster Vaccine Immunogenicity with JAKi Treatment | RheumNowMarch 3rd, 2025- 📊 PRESENTATION BY DR. KEVIN WINTHROP: Adjuvant Recombinant Zoster Vaccine in Patients with RA, Aged ≥50 Years, Treated with a JAKi! View Long-Term Immunogenicity from a Phase 3 Substudy. Sponsored by AbbVie Medical Affairs + Health ImpactFebruary 27th, 2025
- Zoster Vaccine Immunogenicity with JAKi Treatment | RheumNowFebruary 25th, 2025
- Join now to see all
Grant Support
- CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary diseaseOREGON HEALTH & SCIENCE UNIVERSITY2024–2029
- CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary diseaseOREGON HEALTH & SCIENCE UNIVERSITY2024–2029
- Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment responseOREGON HEALTH & SCIENCE UNIVERSITY2024–2028
- Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium InfectionOREGON HEALTH & SCIENCE UNIVERSITY2022–2027
